Echocardiography viva: 60 essential patterns
The echo loops examiners show most often: valve disease and prostheses, cardiomyopathies and the right heart, pericardial disease, masses and thrombi, the aorta, and shunts and congenital heart disease. Each entry gives the echo hallmark, the diagnosis, the clinical risk and the next step, followed by five examiner cross-examination questions.
How to present in the viva: Name the view and modality first (PLAX, PSAX, apical 4-chamber, subcostal; 2D, M-mode, colour, PW/CW Doppler, TEE). Describe the one abnormality you can point to, grade it with a number (gradient, area, EROA, EF), then give the diagnosis and the next step.
AValve disease and prostheses
1.Normal apical 4-chamber view
- Echo hallmark: Correct chamber proportions (RV smaller than LV, basal RV diameter ≤41 mm), intact septa, normal valve opening and closure.
- Diagnosis: Normal Cardiac Anatomy
- Clinical risk: None.
- Management: Establish baseline.
Viva questions (5)
- Q: Normal RV size?A: Basal RV diameter ≤41 mm and the RV about two-thirds the size of the LV in the RV-focused apical 4-chamber view (ASE 2015).
- Q: Best view for the RV?A: RV-focused apical 4-chamber view.
- Q: Normal LVEF?A: About 52–72% in men and 54–74% in women (ASE 2015); 50% or more is generally normal.
- Q: Normal mitral inflow in a young adult?A: E wave larger than A wave.
- Q: Where is the coronary sinus?A: In the posterior AV groove — seen with posterior tilt of the apical 4-chamber view and in the PLAX view.
2.Mitral stenosis
- Echo hallmark: "Hockey-stick" doming of the anterior MV leaflet.
- Diagnosis: Rheumatic Mitral Stenosis
- Clinical risk: LA thrombus, AF.
- Management: Planimetry for MVA (severe ≤1.5 cm²); Wilkins score and MR grade to decide on PTMC.
Viva questions (5)
- Q: What is the classic etiology?A: Rheumatic.
- Q: Why doming?A: Commissural fusion.
- Q: How to measure area?A: Planimetry.
- Q: Pressure half-time in severe MS?A: 150 ms or more (MVA ≈ 220/PHT).
- Q: Main complication?A: Pulmonary hypertension, AF and LA thrombus.
3.Mitral regurgitation
- Echo hallmark: Holosystolic colour flow jet into the Left Atrium.
- Diagnosis: Mitral Regurgitation
- Clinical risk: LV volume overload, heart failure.
- Management: Grade severity: EROA ≥0.4 cm², regurgitant volume ≥60 mL, vena contracta ≥0.7 cm = severe (primary MR).
Viva questions (5)
- Q: Most common cause?A: Degenerative (MVP) in the West; rheumatic disease remains common in India.
- Q: What is the vena contracta?A: The narrowest neck of the jet; ≥0.7 cm indicates severe MR.
- Q: When to operate in severe primary MR?A: Symptoms, or LVEF ≤60% or LVESD ≥40 mm; also new AF or PASP >50 mmHg (ESC 2021 / ACC/AHA 2020).
- Q: What is Flail leaflet?A: Chordal rupture.
- Q: Eccentric jet direction?A: Away from the affected leaflet — posterior leaflet prolapse directs the jet anteriorly.
4.Aortic stenosis
- Echo hallmark: Thickened, calcified, restricted leaflet opening.
- Diagnosis: Calcific Aortic Stenosis
- Clinical risk: Sudden death, heart failure.
- Management: CW Doppler from several windows: severe = peak velocity ≥4 m/s, mean gradient ≥40 mmHg, AVA ≤1.0 cm².
Viva questions (5)
- Q: Severe mean gradient?A: ≥40 mmHg (peak velocity ≥4 m/s).
- Q: Severe valve area?A: ≤1.0 cm² (indexed ≤0.6 cm²/m²).
- Q: Low-gradient AS with low EF?A: Low-dose dobutamine stress echo; with preserved EF, CT calcium scoring helps.
- Q: Typical patient?A: Calcific AS in the elderly (>65–70 years); bicuspid valve in younger patients.
- Q: Why use several windows?A: To align the CW Doppler beam with the jet — apical, right parasternal and suprasternal.
5.Aortic regurgitation
- Echo hallmark: Diastolic colour jet from the aortic valve into the LVOT; fluttering of the anterior mitral leaflet on M-mode.
- Diagnosis: Aortic Regurgitation
- Clinical risk: LV dilation, acute heart failure.
- Management: Grade severity: vena contracta >0.6 cm, pressure half-time <200 ms, holodiastolic flow reversal in the descending aorta.
Viva questions (5)
- Q: Why flutter?A: Regurgitant jet striking the leaflet.
- Q: Chronic signs?A: LV dilation.
- Q: Acute AR?A: Premature MV closure.
- Q: Which view?A: PLAX.
- Q: Indication for surgery in chronic severe AR?A: Symptoms, or LVEF ≤50% (≤55% ACC/AHA) or LVESD >50 mm (>25 mm/m²) (ESC 2021).
6.Mitral valve prolapse
- Echo hallmark: Leaflet displacement >2mm above the mitral annulus in PLAX.
- Diagnosis: MVP
- Clinical risk: Mitral regurgitation, chordal rupture.
- Management: Monitor for MR severity.
Viva questions (5)
- Q: Why the click?A: Sudden tensing of chordae.
- Q: Risk?A: Chordal rupture.
- Q: Best view?A: PLAX.
- Q: Association?A: Marfan syndrome.
- Q: When to operate?A: Severe primary MR with symptoms, LVEF ≤60%, LVESD ≥40 mm, new AF or PASP >50 mmHg.
7.Mitral annular calcification
- Echo hallmark: Highly echogenic area along the posterior mitral annulus.
- Diagnosis: MAC
- Clinical risk: Conduction abnormalities, MS/MR.
- Management: Assess valve function and rhythm.
Viva questions (5)
- Q: Age?A: Elderly.
- Q: Conduction?A: Heart block risk.
- Q: What can it mimic?A: Vegetation, abscess or mass (caseous MAC).
- Q: Risk?A: Stroke.
- Q: Treatment?A: No specific therapy; manage associated MS or MR and risk factors — valve intervention is high risk in heavy MAC.
8.Bicuspid aortic valve
- Echo hallmark: Systolic "doming" and eccentric closure line.
- Diagnosis: BAV
- Clinical risk: Aortic stenosis, Aortic aneurysm, Coarctation.
- Management: Serial aortic diameter monitoring.
Viva questions (5)
- Q: Closure?A: Eccentric.
- Q: Association?A: Coarctation.
- Q: Aorta risk?A: Aortic dilation.
- Q: Inheritance?A: Autosomal dominant.
- Q: Screening?A: Family echocardiography.
9.Flail mitral leaflet
- Echo hallmark: Leaflet tip pointing into LA during systole.
- Diagnosis: Flail Mitral Valve
- Clinical risk: Severe MR.
- Management: Early surgery — mitral repair where possible.
Viva questions (5)
- Q: Why flail?A: Chordal rupture.
- Q: Jet?A: Eccentric/Wall hugging.
- Q: Complication?A: Pulmonary oedema.
- Q: Anatomy?A: Prolapse + rupture.
- Q: Surgery?A: Early repair; urgent if acute severe MR with pulmonary ooedema or shock.
10.Carcinoid heart disease
- Echo hallmark: Thickened, retracted, and immobile tricuspid valve leaflets stuck in an open position.
- Diagnosis: Carcinoid Heart Disease
- Clinical risk: Severe isolated right-sided heart failure.
- Management: Somatostatin analogues, diuretics; bioprosthetic tricuspid (± pulmonary) valve replacement.
Viva questions (5)
- Q: Which valves are affected?A: Right-sided valves (Tricuspid and Pulmonary).
- Q: Why are left valves usually spared?A: Inactivation of vasoactive substances by the lungs.
- Q: What is the primary lesion?A: Endocardial plaque deposition.
- Q: Does it cause stenosis or regurgitation?A: Usually severe regurgitation.
- Q: Exception where left valves are involved?A: Patent Foramen Ovale or bronchial carcinoid.
11.Normal mechanical prosthetic valve
- Echo hallmark: Highly echogenic prosthesis with reverberation and acoustic shadowing; normal disc or leaflet excursion.
- Diagnosis: Normal Mechanical Valve
- Clinical risk: Pannus/Thrombus.
- Management: Doppler assessment of gradients.
Viva questions (5)
- Q: Normal gradient?A: Varies by valve type and size — compare with the post-operative baseline study and the Doppler velocity index.
- Q: What is Pannus?A: Tissue overgrowth.
- Q: Thrombus differentiation?A: TEE.
- Q: What to report?A: Velocity/Mean gradient.
- Q: Complication?A: Haemolysis.
12.Prosthetic valve obstruction
- Echo hallmark: Elevated velocity/gradient on CW Doppler.
- Diagnosis: Prosthetic Valve Stenosis
- Clinical risk: Valve failure/Thrombosis.
- Management: TEE to exclude thrombus/pannus.
Viva questions (5)
- Q: Why obstructed?A: Pannus vs Thrombus.
- Q: TEE role?A: Leaflet mobility.
- Q: Doppler clue to aortic prosthesis obstruction?A: Doppler velocity index <0.25 and prolonged acceleration time.
- Q: Treatment?A: Left-sided obstructive thrombosis: urgent surgery (fibrinolysis if surgery is high risk); pannus: redo surgery.
- Q: Role of anticoagulation?A: Check adequacy; non-obstructive thrombus is treated with optimised anticoagulation and close follow-up.
BCardiomyopathy, ischaemia and the right heart
13.Hypertrophic cardiomyopathy
- Echo hallmark: Asymmetric septal hypertrophy ≥15 mm (≥13 mm with a family history), with systolic anterior motion (SAM) of the mitral valve.
- Diagnosis: HCM
- Clinical risk: LVOT obstruction, sudden death.
- Management: Beta-blocker or verapamil; mavacamten for obstructive HCM; septal myectomy or alcohol septal ablation if refractory; ICD by risk score.
Viva questions (5)
- Q: What is SAM?A: Anterior leaflet hits septum.
- Q: Significant LVOT gradient?A: ≥30 mmHg indicates obstruction; ≥50 mmHg (rest or provoked) is the threshold for septal reduction in symptomatic patients.
- Q: How to provoke the gradient?A: Valsalva, standing or exercise echocardiography.
- Q: Echo finding?A: Asymmetric septal hypertrophy.
- Q: Surgery?A: Myectomy.
14.Dilated cardiomyopathy
- Echo hallmark: Globally dilated LV with poor global contractility (low EF).
- Diagnosis: DCM
- Clinical risk: Heart failure, arrhythmias.
- Management: GDMT (Guidelines-Directed Medical Therapy).
Viva questions (5)
- Q: Definition?A: LV dilatation and systolic dysfunction not explained by abnormal loading conditions or coronary artery disease (ESC 2023).
- Q: Causes?A: Idiopathic, viral, ischemic.
- Q: M-mode clue to raised LVEDP?A: B-bump on the mitral valve; increased E-point septal separation (>7 mm) indicates low EF.
- Q: Echo?A: Dilated chambers.
- Q: Prognosis?A: Depends on recovery.
15.Regional wall motion abnormality
- Echo hallmark: Segmental hypokinesia/akinesia/dyskinesia.
- Diagnosis: Regional Wall Motion Abnormality
- Clinical risk: Ischemic heart disease.
- Management: Coronary angiography.
Viva questions (5)
- Q: Vascular territory?A: LAD/RCA/LCx.
- Q: Hibernating?A: Viable but non-contractile.
- Q: Stunned?A: Post-ischemic.
- Q: Imaging?A: Stress Echo/CMR.
- Q: Clinical?A: Previous MI.
16.Paradoxical septal motion
- Echo hallmark: Septal movement away from the LV posterior wall in systole.
- Diagnosis: Paradoxical Septal Motion
- Clinical risk: Post-CABG, LBBB, RV overload.
- Management: Identify cause.
Viva questions (5)
- Q: Cause 1?A: LBBB.
- Q: Cause 2?A: Post-cardiac surgery.
- Q: Cause 3?A: RV volume overload.
- Q: Meaning?A: Abnormal septal activation/loading.
- Q: Significance?A: Common post-open heart.
17.Stunning vs hibernation
- Echo hallmark: Regional wall motion abnormality (RWMA) with wall thinning (scar) or normal thickness (viable).
- Diagnosis: Ischemic Cardiomyopathy
- Clinical risk: Heart failure, ventricular aneurysm.
- Management: CMR or Dobutamine Stress Echo for viability assessment.
Viva questions (5)
- Q: Definition of stunning?A: Post-ischemic dysfunction, viable.
- Q: Definition of hibernation?A: Chronic hypoperfusion, viable.
- Q: How to tell them apart?A: Both show contractile reserve on low-dose dobutamine; resting perfusion is normal in stunning and reduced in hibernation.
- Q: What is a true aneurysm?A: Scar tissue outpouching with thinned wall.
- Q: What is a pseudoaneurysm?A: Contained rupture.
18.Stress echocardiography (ischaemia)
- Echo hallmark: New regional wall motion abnormality under stress.
- Diagnosis: Stress-Induced Ischemia
- Clinical risk: CAD.
- Management: Coronary angiography.
Viva questions (5)
- Q: Why stress?A: Demand ischemia.
- Q: Ischemia sign?A: New RWMA.
- Q: What if EF drops?A: Severe multi-vessel disease.
- Q: Accuracy?A: Sensitivity about 80–85% and specificity 85–90%.
- Q: Contraindications?A: Severe symptomatic AS, acute coronary syndrome, uncontrolled arrhythmia or hypertension.
19.Cardiac amyloidosis
- Echo hallmark: Thick ventricles with granular “sparkling” myocardium, bi-atrial enlargement, small effusion and relative apical sparing of longitudinal strain.
- Diagnosis: Amyloidosis
- Clinical risk: HFpEF.
- Management: Bone scintigraphy plus serum free light chains and serum/urine immunofixation; CMR; biopsy if needed.
Viva questions (5)
- Q: What is sparkling?A: Myocardial infiltration.
- Q: Filling?A: Restrictive.
- Q: ECG?A: Low voltage.
- Q: First line test?A: Echo.
- Q: Treatment?A: ATTR: tafamidis (TTR stabiliser); AL: chaemotherapy.
20.Restrictive cardiomyopathy
- Echo hallmark: Dilated atria, normal/thick ventricles, restrictive filling pattern.
- Diagnosis: Restrictive Cardiomyopathy
- Clinical risk: Progressive heart failure.
- Management: Treat the cause (e.g., tafamidis for ATTR amyloid); diuretics, rate control.
Viva questions (5)
- Q: Echo?A: Bi-atrial enlargement.
- Q: Filling pattern?A: E/A >2 with deceleration time <150 ms; low e′ (<7 cm/s).
- Q: Difference from constrictive?A: No respiratory variation.
- Q: Causes?A: Amyloidosis, sarcoidosis, haemochromatosis, Fabry disease, radiation, endomyocardial fibrosis.
- Q: EF?A: Preserved.
21.LV apical aneurysm
- Echo hallmark: Outpouching of the LV apex with thinned, akinetic/dyskinetic walls during systole and diastole.
- Diagnosis: LV Apical Aneurysm
- Clinical risk: Thrombus formation, systemic embolism, and ventricular arrhythmias.
- Management: Anticoagulation if thrombus; GDMT; ICD by LVEF and arrhythmia criteria.
Viva questions (5)
- Q: Differentiate true aneurysm from pseudoaneurysm?A: True aneurysm has a wide neck; pseudoaneurysm has a narrow neck.
- Q: Which coronary artery is occluded?A: Left Anterior Descending (LAD).
- Q: Does a true aneurysm rupture?A: Rarely, due to dense scarring.
- Q: What is the classic ECG finding?A: Persistent ST elevation in anterior leads.
- Q: Is it contractile?A: No, it is dyskinetic or akinetic.
22.LV non-compaction (hypertrabeculation)
- Echo hallmark: Deep intertrabecular recesses in the LV apex with a non-compacted to compacted ratio > 2:1 at end-systole.
- Diagnosis: LVNC
- Clinical risk: Heart failure, thromboembolism, and malignant arrhythmias.
- Management: Anticoagulation if AF, LV thrombus, prior embolism or severely reduced LVEF; GDMT; ICD by standard criteria.
Viva questions (5)
- Q: How do you confirm flow in recesses?A: Colour Doppler shows blood entering the deep trabeculations.
- Q: What is the embryological cause?A: Arrest of normal myocardial compaction.
- Q: Which segments are most affected?A: Apical and mid-ventricular segments.
- Q: MRI criteria?A: Ratio of non-compacted to compacted myocardium > 2.3.
- Q: Is it genetic?A: Highly familial, often autosomal dominant.
23.Cardiac sarcoidosis
- Echo hallmark: Patchy basal septal thinning, localized aneurysms, or focal wall thickening not in a coronary territory.
- Diagnosis: Cardiac Sarcoidosis
- Clinical risk: Complete heart block, Ventricular Tachycardia, Sudden Cardiac Death.
- Management: Immunosuppression (corticosteroids, methotrexate); ICD if LVEF ≤35%, sustained VT or a pacing indication with risk features.
Viva questions (5)
- Q: What is the most common presenting rhythm?A: Complete heart block in a young patient.
- Q: Best imaging modality?A: Cardiac MRI or FDG-PET.
- Q: What does MRI show?A: Patchy late gadolinium enhancement, often mid-wall or epicardial.
- Q: Can it mimic HCM?A: Yes, through focal granulomatous thickening.
- Q: Why is it often missed on endomyocardial biopsy?A: Patchy distribution leads to sampling error.
24.D-shaped LV
- Echo hallmark: Flattened interventricular septum making the LV D-shaped in both systole and diastole, maximal at end-systole.
- Diagnosis: RV Pressure Overload
- Clinical risk: Severe pulmonary hypertension/Massive PE.
- Management: Assess PASP and RV function.
Viva questions (5)
- Q: Why D-shape?A: High RV pressure.
- Q: Condition?A: Cor Pulmonale/pulmonary hypertension.
- Q: Timing?A: Systole + Diastole.
- Q: Flattening in diastole only?A: RV volume overload (e.g., ASD, severe TR).
- Q: Diagnosis?A: pulmonary hypertension.
25.Cor pulmonale (severe pulmonary hypertension)
- Echo hallmark: Dilated right ventricle, paradoxical septal motion (D-shaped LV in systole and diastole), and severe TR.
- Diagnosis: Cor Pulmonale
- Clinical risk: Right ventricular failure, low cardiac output.
- Management: Right heart catheterization for haemodynamics and targeted PAH therapy.
Viva questions (5)
- Q: How do you estimate PA systolic pressure?A: 4 × (peak TR velocity)² + estimated RA pressure.
- Q: What causes a D-shaped LV in diastole?A: RV volume overload.
- Q: What causes a D-shaped LV in systole?A: RV pressure overload.
- Q: Normal RV size?A: Basal RV diameter ≤41 mm in the RV-focused apical 4-chamber view (ASE 2015).
- Q: What happens to the IVC?A: Plethoric and non-collapsible.
CPericardial disease
26.Pericardial effusion
- Echo hallmark: Echo-free space between epicardium and pericardium.
- Diagnosis: Pericardial Effusion
- Clinical risk: Tamponade.
- Management: Echo for haemodynamic impact.
Viva questions (5)
- Q: Best view?A: Subcostal/Parasternal.
- Q: Pericardial vs pleural effusion?A: Pericardial fluid lies anterior to the descending aorta; pleural fluid lies posterior to it.
- Q: Tamponade sign?A: RA/RV collapse.
- Q: How do you grade size?A: End-diastolic echo-free space: small <10 mm, moderate 10–20 mm, large >20 mm.
- Q: Tamponade management?A: Pericardiocentesis.
27.Cardiac tamponade
- Echo hallmark: Early-diastolic RV collapse, RA collapse in late diastole/early systole, plethoric IVC.
- Diagnosis: Cardiac Tamponade
- Clinical risk: Obstructive shock.
- Management: Urgent pericardiocentesis.
Viva questions (5)
- Q: Why RV collapse?A: RV is low pressure.
- Q: Respiratory variation?A: Mitral inflow falls by >25–30% and tricuspid inflow rises by >40% with inspiration.
- Q: IVC?A: Plethoric (non-collapsible).
- Q: Beck's Triad?A: Hypotension, JVP, Muffled heart sounds.
- Q: First-line treatment?A: Urgent pericardiocentesis; IV fluids only as a temporising measure if hypovolaemic; avoid positive-pressure ventilation.
28.Constrictive pericarditis
- Echo hallmark: Septal bounce and respiratory variation in mitral inflow (>25%).
- Diagnosis: Constrictive Pericarditis
- Clinical risk: Heart failure.
- Management: Pericardiectomy.
Viva questions (5)
- Q: What is the septal bounce?A: An abrupt early-diastolic septal shift from ventricular interdependence.
- Q: Respiratory variation?A: Ventricular interdependence.
- Q: Hepatic vein?A: Diastolic flow reversal.
- Q: IVC?A: Plethoric.
- Q: Tissue Doppler clue?A: Annulus reversus (medial e′ higher than lateral e′) and preserved or high e′ — unlike restriction.
DMasses, thrombi and endocarditis
29.Vegetation (infective endocarditis)
- Echo hallmark: Oscillating, mobile mass attached to the atrial side of AV valves or ventricular side of semilunar valves.
- Diagnosis: Infective Endocarditis
- Clinical risk: Embolism.
- Management: Blood cultures, Duke’s criteria, TEE.
Viva questions (5)
- Q: Most common site?A: Valve leaflet.
- Q: What are the Duke criteria?A: Diagnostic criteria for endocarditis (ESC 2023 / Duke-ISCVID 2023): major — positive blood cultures and imaging evidence; plus minor criteria.
- Q: Embolism risk?A: Size >10mm.
- Q: TEE vs TTE?A: TEE is superior.
- Q: First step?A: Blood cultures.
30.Left atrial myxoma
- Echo hallmark: Mobile, pedunculated mass attached to the interatrial septum near the fossa ovalis; may prolapse through the mitral valve in diastole.
- Diagnosis: Left Atrial Myxoma
- Clinical risk: Embolism, valvular obstruction.
- Management: Urgent surgical resection.
Viva questions (5)
- Q: Most common benign tumour?A: Myxoma.
- Q: Where attached?A: IAS (fossa ovalis).
- Q: Systemic symptom?A: Constitutional (fever/weight loss).
- Q: Auscultation?A: Tumour plop.
- Q: Risk?A: Embolism.
31.Left atrial thrombus
- Echo hallmark: Non-mobile, layered mass in LAA or LA.
- Diagnosis: Left Atrial Thrombus
- Clinical risk: Systemic embolization.
- Management: Anticoagulation (VKA or DOAC); repeat TEE before cardioversion.
Viva questions (5)
- Q: Best view for LAA?A: TEE (0°-135°).
- Q: How to differentiate from myxoma?A: Attachment site/mobility.
- Q: AF association?A: Yes.
- Q: Appearance?A: Echogenic/layered.
- Q: Treatment?A: Anticoagulation (heparin then VKA or DOAC); defer cardioversion until the thrombus has resolved.
32.LV apical thrombus
- Echo hallmark: Echogenic mass in the LV apex associated with akinesia.
- Diagnosis: Apical LV Thrombus
- Clinical risk: Systemic embolism.
- Management: Anticoagulation.
Viva questions (5)
- Q: Associated condition?A: Anterior MI/Dilated CM.
- Q: How to improve detection?A: Contrast echo; CMR is the most sensitive.
- Q: Risk?A: Embolism.
- Q: How long to anticoagulate?A: Usually 3–6 months (VKA or DOAC), guided by repeat imaging (ESC 2023).
- Q: Appearance?A: Laminated/Echogenic.
33.Right heart thrombus in transit
- Echo hallmark: Serpentine, highly mobile echogenic mass moving freely within the RA or across the tricuspid valve.
- Diagnosis: RA Thrombus
- Clinical risk: Massive Pulmonary Embolism.
- Management: Urgent surgical embolectomy, thrombolysis, or anticoagulation based on stability.
Viva questions (5)
- Q: Where does it originate?A: Deep veins of the lower extremities (DVT).
- Q: Classic appearance?A: "Popcorn" or "snake-like" moving with the cardiac cycle.
- Q: Differentiate from Chiari network?A: Chiari network is thin, web-like, attached to IVC/CS, and benign.
- Q: Mortality rate?A: Very high if it embolizes to the pulmonary tree.
- Q: Immediate action during Echo?A: Limit patient movement, arrange emergent intervention.
34.Cardiac metastasis
- Echo hallmark: Irregular, non-encapsulated echogenic mass involving the pericardium or myocardium, often with pericardial effusion.
- Diagnosis: Cardiac Tumour (Metastasis)
- Clinical risk: Pericardial tamponade, arrhythmias, obstruction.
- Management: Palliative care, pericardiocentesis, treating underlying primary.
Viva questions (5)
- Q: Are primary or secondary cardiac tumours more common?A: Secondary (Metastatic) are 20-40 times more common.
- Q: Most common primary sources?A: Melanoma, Lung, Breast.
- Q: How do they reach the heart?A: Lymphatic, hematogenous, or direct extension.
- Q: Most common cardiac site for metastasis?A: Pericardium.
- Q: What is the most common primary malignant cardiac tumour?A: Angiosarcoma (usually in the RA).
EAorta and coronary anomalies
35.Aortic root aneurysm
- Echo hallmark: Dilated aortic root (>40mm).
- Diagnosis: Aortic Root Aneurysm
- Clinical risk: Rupture/Dissection.
- Management: Surgical criteria assessment.
Viva questions (5)
- Q: Surgical threshold for the root?A: ≥55 mm; ≥50 mm in Marfan syndrome or bicuspid valve with risk factors (ESC 2024).
- Q: View?A: PLAX.
- Q: Association?A: BAV.
- Q: Follow-up?A: Serial echo/CT.
- Q: Treatment?A: Surgery.
36.Complex aortic atheroma (TEE)
- Echo hallmark: Protruding, mobile, or ulcerated echogenic mass (>4mm thick) in the descending aorta on TEE.
- Diagnosis: Complex Aortic Atheroma
- Clinical risk: Embolic stroke, peripheral arterial occlusion.
- Management: High-intensity statin and antiplatelet therapy.
Viva questions (5)
- Q: Why use TEE?A: TTE cannot adequately visualize the descending thoracic aorta.
- Q: What makes it "complex"?A: Thickness > 4mm, ulceration, or mobile elements.
- Q: Embolism type?A: Thromboembolism and cholesterol crystal embolism.
- Q: Clinical sign of embolization?A: Livedo reticularis, blue toe syndrome, acute renal failure.
- Q: Is anticoagulation recommended?A: Generally no, unless there is a mobile thrombus attached.
37.Coronary artery fistula
- Echo hallmark: Abnormal colour Doppler continuous flow entering a cardiac chamber from a dilated coronary artery.
- Diagnosis: Coronary Fistula
- Clinical risk: Coronary steal syndrome resulting in ischemia.
- Management: Coil embolization or surgical ligation.
Viva questions (5)
- Q: Most common origin?A: Right coronary artery (RCA).
- Q: Most common drainage site?A: Right ventricle.
- Q: Murmur?A: Continuous machinery murmur.
- Q: What happens to the feeding vessel?A: It becomes massively dilated and tortuous.
- Q: Complications?A: Heart failure, endocarditis, aneurysm rupture.
38.Sinus of Valsalva aneurysm
- Echo hallmark: "Wind-sock" deformity or outpouching of the aortic sinus into adjacent structures.
- Diagnosis: Sinus of Valsalva Aneurysm
- Clinical risk: Rupture leading to acute heart failure (usually into RA or RV).
- Management: Surgical repair.
Viva questions (5)
- Q: Which sinus is most commonly involved?A: Right coronary sinus.
- Q: What structure does it usually rupture into?A: Right Ventricle.
- Q: What does a rupture look like on Echo?A: Continuous high-velocity jet from aorta to RV.
- Q: Associated congenital defect?A: Ventricular Septal Defect (VSD).
- Q: Clinical presentation of rupture?A: Sudden onset chest pain and continuous murmur.
FShunts and congenital heart disease
39.Secundum ASD
- Echo hallmark: Colour flow jet crossing the IAS (L to R).
- Diagnosis: Secundum ASD
- Clinical risk: RV volume overload.
- Management: Assess RV size and Qp:Qs; device or surgical closure if RV volume overload and PVR acceptable.
Viva questions (5)
- Q: Best view?A: Subcostal.
- Q: Why subcostal?A: The beam is perpendicular to the septum, avoiding false drop-out seen in the apical 4-chamber view.
- Q: Sign of overload?A: RV dilation.
- Q: What is a sinus venosus ASD?A: A defect near the SVC (or IVC) entry, outside the fossa ovalis, usually with anomalous right pulmonary veins.
- Q: Closure?A: Device or surgery.
40.Ventricular septal defect
- Echo hallmark: High-velocity colour/Doppler jet across the interventricular septum.
- Diagnosis: VSD
- Clinical risk: Pulmonary over-circulation, pulmonary hypertension.
- Management: Qp:Qs calculation.
Viva questions (5)
- Q: Types?A: Perimembranous, Muscular.
- Q: Why high velocity?A: Pressure gradient.
- Q: Complication?A: Eisenmenger.
- Q: Large vs small VSD murmur?A: Small restrictive VSDs are loud; large non-restrictive VSDs may have a soft or no murmur.
- Q: Shunt?A: L to R.
41.Patent ductus arteriosus
- Echo hallmark: Continuous high-velocity colour jet into the main pulmonary artery in the parasternal short-axis (ductal) view.
- Diagnosis: PDA
- Clinical risk: Left heart volume overload, Pulmonary Hypertension.
- Management: Transcatheter closure or surgical ligation.
Viva questions (5)
- Q: Why is the jet continuous?A: Aortic pressure is higher than PA pressure in both systole and diastole.
- Q: Which chambers dilate?A: LA and LV.
- Q: Medical closure in neonates?A: Indomethacin or Ibuprofen.
- Q: Reversal of flow signifies what?A: Eisenmenger syndrome.
- Q: What happens to the pulses?A: Bounding pulses due to wide pulse pressure.
42.Total anomalous pulmonary venous return
- Echo hallmark: Absence of pulmonary veins entering the LA; presence of a common venous confluence behind the LA.
- Diagnosis: TAPVR
- Clinical risk: Severe cyanosis, pulmonary oedema (if obstructed).
- Management: Emergency surgical redirection of veins to the LA.
Viva questions (5)
- Q: Is it a cyanotic defect?A: Yes.
- Q: What is required for survival?A: An obligate right-to-left shunt (ASD or PFO).
- Q: Most common type?A: Supracardiac (draining into SVC via vertical vein).
- Q: Which type is most commonly obstructed?A: Infracardiac (draining below the diaphragm).
- Q: CXR sign for supracardiac?A: Snowman heart.
43.Truncus arteriosus
- Echo hallmark: A single large arterial trunk overriding a large VSD, giving rise to systemic, pulmonary, and coronary circulations.
- Diagnosis: Truncus Arteriosus
- Clinical risk: Early, severe pulmonary hypertension.
- Management: Early surgical repair (VSD closure and RV–PA conduit, Rastelli-type).
Viva questions (5)
- Q: What is the status of the truncal valve?A: Frequently dysplastic and regurgitant.
- Q: Genetic association?A: DiGeorge syndrome (22q11 deletion).
- Q: Why severe pulmonary hypertension?A: Pulmonary bed is exposed to systemic pressures.
- Q: Is the VSD necessary?A: Yes, for LV output.
- Q: What does the surgery involve?A: Closing VSD, separating PA, and placing a conduit.
44.d-Transposition of the great arteries
- Echo hallmark: Parallel outflow tracts in the parasternal long axis; Aorta arises anteriorly from RV, PA arises posteriorly from LV.
- Diagnosis: D-TGA
- Clinical risk: Profound hypoxia incompatible with life without mixing.
- Management: PGE1 infusion, balloon atrial septostomy, then Arterial Switch.
Viva questions (5)
- Q: What is the defining anatomical feature?A: Ventriculoarterial discordance.
- Q: Why do parallel outflow tracts occur?A: Failure of the normal spiraling of the conotruncal septum.
- Q: What is the Jatene procedure?A: Arterial switch with coronary reimplantation.
- Q: CXR finding?A: "Egg on a string" appearance.
- Q: What maintains ductal patency?A: Prostaglandin E1.
45.Double outlet right ventricle
- Echo hallmark: Both the aorta and pulmonary artery arise entirely or predominantly (>50%) from the morphologic right ventricle.
- Diagnosis: DORV
- Clinical risk: Cyanosis and heart failure.
- Management: Complex biventricular repair.
Viva questions (5)
- Q: How does LV blood exit?A: Must pass through a VSD.
- Q: What determines the clinical presentation?A: The location of the VSD relative to the great arteries.
- Q: What is a Taussig-Bing anomaly?A: DORV with a subpulmonary VSD.
- Q: Is there aortic-mitral continuity?A: No, usually there is bilateral conus preventing continuity.
- Q: Standard surgery?A: Intraventricular baffle routing LV to aorta.
46.Pulmonary atresia with intact septum
- Echo hallmark: Imperforate pulmonary valve with a hypoplastic, thickened right ventricle and intact septum.
- Diagnosis: PA-IVS
- Clinical risk: Severe cyanosis, ductal-dependent pulmonary circulation.
- Management: PGE1; radiofrequency perforation and balloon valvotomy if the RV is adequate and no RV-dependent coronary circulation; otherwise a systemic-to-pulmonary shunt.
Viva questions (5)
- Q: What is the status of the Tricuspid Valve?A: Usually hypoplastic and severely regurgitant.
- Q: What are right-ventricle dependent coronary circulations?A: Fistulae connecting the high-pressure RV to coronary arteries.
- Q: Why are these fistulae dangerous?A: Decompressing the RV causes myocardial ischemia.
- Q: Ductal dependent?A: Yes.
- Q: Ultimate surgical pathway?A: Depends on RV size; may require single ventricle (Fontan) routing.
47.Cor triatriatum sinister
- Echo hallmark: A fibromuscular membrane dividing the Left Atrium into a proximal (receiving) and distal (valvar) chamber.
- Diagnosis: Cor Triatriatum
- Clinical risk: Mimics severe Mitral Stenosis, causing pulmonary oedema.
- Management: Surgical resection of the membrane.
Viva questions (5)
- Q: What determines the severity?A: The size of the fenestration in the membrane.
- Q: Cor triatriatum vs supramitral ring?A: The cor triatriatum membrane lies above the LA appendage; a supramitral ring lies below it, close to the mitral leaflets.
- Q: Where does the LAA attach?A: To the distal (true) chamber.
- Q: Does it cause LV enlargement?A: No, LV is underfilled.
- Q: Curative treatment?A: Excision of the membrane.
48.Persistent left SVC
- Echo hallmark: Massively dilated coronary sinus seen in the parasternal long axis view.
- Diagnosis: Persistent LSVC
- Clinical risk: Benign, but causes issues during central line placement or pacemaker lead insertion.
- Management: Confirm diagnosis with agitated saline contrast in the left arm.
Viva questions (5)
- Q: What is the embryological cause?A: Failure of the left anterior cardinal vein to obliterate.
- Q: Where does it drain?A: Into the Right Atrium via the Coronary Sinus.
- Q: How to prove it with contrast?A: Saline in left arm opacifies the Coronary Sinus before the RA.
- Q: Is the Right SVC present?A: Yes, in 80-90% of cases.
- Q: When does it cause cyanosis?A: Only if the coronary sinus is unroofed (draining to LA).
49.Sinus venosus ASD
- Echo hallmark: Defect located high in the atrial septum near the SVC entrance, best seen in the subcostal or TEE bicaval view.
- Diagnosis: Sinus Venosus ASD
- Clinical risk: RV volume overload.
- Management: Surgical repair (patch or Warden procedure); covered-stent transcatheter repair is an option in selected patients.
Viva questions (5)
- Q: What is almost always associated with this defect?A: Partial Anomalous Pulmonary Venous Return (PAPVR).
- Q: Which veins are anomalous?A: Right upper pulmonary veins.
- Q: Can it be closed with a device?A: Not with a septal occluder; surgery is standard, and covered-stent transcatheter repair is emerging.
- Q: ECG clue?A: Low or leftward P-wave axis (ectopic atrial rhythm); QRS axis normal or rightward.
- Q: Best Echo view?A: TEE bicaval view.
50.Unroofed coronary sinus
- Echo hallmark: Absence of the tissue separating the coronary sinus from the left atrium.
- Diagnosis: Unroofed Coronary Sinus
- Clinical risk: Paradoxical embolism, Right-to-Left shunting if associated with LSVC.
- Management: Surgical patch repair.
Viva questions (5)
- Q: What is the physiological consequence?A: It acts as an Atrial Septal Defect.
- Q: What congenital anomaly is heavily associated?A: Persistent Left SVC.
- Q: Best imaging modality?A: TEE or Cardiac MRI.
- Q: Risk of unroofed CS with LSVC?A: Desaturated blood flows directly into the Left Atrium.
- Q: Symptoms?A: Often asymptomatic unless large shunt or systemic embolus occurs.
51.Aortopulmonary window
- Echo hallmark: Large defect between the ascending aorta and the main pulmonary artery, with separate, distinct aortic and pulmonary valves.
- Diagnosis: AP Window
- Clinical risk: Massive Left-to-Right shunt, early severe pulmonary hypertension.
- Management: Early surgical closure.
Viva questions (5)
- Q: How does it differ from Truncus Arteriosus?A: AP window has two distinct semilunar valves.
- Q: How does it differ from a PDA?A: Located proximally between ascending aorta and main PA.
- Q: Murmur type?A: Often systolic (not continuous like PDA) due to equalization of diastolic pressures.
- Q: Complication if untreated?A: Eisenmenger syndrome in infancy.
- Q: Closure method?A: Usually patch closure.
52.Double inlet left ventricle
- Echo hallmark: Both the mitral and tricuspid valves (or a common AV valve) open entirely into a single morphological left ventricle.
- Diagnosis: DILV
- Clinical risk: Cyanosis, heart failure.
- Management: Staged palliation towards Fontan circulation.
Viva questions (5)
- Q: What is the status of the right ventricle?A: Hypoplastic, acting as an outflow chamber.
- Q: How does blood reach the great artery from the hypoplastic RV?A: Through a Bulboventricular Foramen (VSD).
- Q: Is mixing complete?A: Yes, complete mixing in the main LV chamber.
- Q: Great artery arrangement?A: Often transposed (L-TGA position).
- Q: Surgical goal?A: Volume unload the single ventricle (Glenn, then Fontan).
53.Hypoplastic left heart syndrome
- Echo hallmark: Severe hypoplasia of the LV, Mitral Atresia, and Aortic Atresia.
- Diagnosis: HLHS
- Clinical risk: Rapid cardiogenic shock and death upon ductal closure.
- Management: Prostaglandin E1, followed by Norwood Procedure.
Viva questions (5)
- Q: Is it ductal dependent for systemic blood flow?A: Yes, entirely.
- Q: What is the obligatory shunt for survival?A: Left-to-Right flow across an ASD.
- Q: What if the atrial septum is intact?A: Immediate mortality; requires emergent balloon septostomy.
- Q: What is Stage 1 surgery?A: Norwood (creates neo-aorta from PA and provides BT shunt).
- Q: What handles both systemic and pulmonary circulation?A: The Right Ventricle.
54.Pulmonary artery sling
- Echo hallmark: Anomalous origin of the Left Pulmonary Artery from the posterior aspect of the Right Pulmonary Artery.
- Diagnosis: PA Sling
- Clinical risk: Severe tracheobronchial compression.
- Management: Surgical reimplantation of the LPA.
Viva questions (5)
- Q: How does the LPA course?A: It courses between the trachea and the esophagus.
- Q: What does it form?A: A vascular sling around the distal trachea.
- Q: What is heavily associated with this?A: Complete tracheal rings.
- Q: Symptom presentation?A: Severe stridor and respiratory distress in infancy.
- Q: Differentiate from double aortic arch?A: Sling passes between trachea and esophagus; double arch encircles both.
55.Kawasaki coronary aneurysms
- Echo hallmark: Echo-bright, dilated, and aneurysmal coronary arteries, specifically the proximal RCA and LAD.
- Diagnosis: Kawasaki Disease
- Clinical risk: Coronary thrombosis, Myocardial Infarction.
- Management: IVIG and aspirin acutely; anticoagulation plus antiplatelet therapy for giant aneurysms.
Viva questions (5)
- Q: What defines a giant aneurysm?A: Internal diameter ≥8 mm or Z-score ≥10 (AHA 2017).
- Q: Why do they thrombose?A: Sluggish blood flow within the aneurysm.
- Q: What is the primary cause of death?A: Myocardial Infarction.
- Q: When do aneurysms typically develop?A: Subacute phase (weeks 2-4).
- Q: Do they regress?A: Small ones may, giant ones rarely do.
56.Shone complex
- Echo hallmark: Serial left-sided obstructive lesions: Supramitral ring, parachute mitral valve, subaortic stenosis, and coarctation of the aorta.
- Diagnosis: Shone Complex
- Clinical risk: Severe heart failure, pulmonary hypertension.
- Management: Complex multi-stage surgical relief of obstructions.
Viva questions (5)
- Q: What defines a parachute mitral valve?A: All chordae attach to a single papillary muscle.
- Q: Does the patient have to have all four lesions?A: No, partial variants exist.
- Q: What is the underlying developmental issue?A: Underdevelopment of the left-sided structures.
- Q: Which lesion usually dictates the symptoms first?A: Coarctation or severe MS.
- Q: Can you fix it all at once?A: Rarely, usually requires staged repairs starting with the aorta.
57.Double aortic arch
- Echo hallmark: The ascending aorta splits into two arches that encircle the trachea and esophagus, rejoining at the descending aorta.
- Diagnosis: Double Aortic Arch (Vascular Ring)
- Clinical risk: Dysphagia and severe stridor.
- Management: Surgical division of the smaller (usually left) arch.
Viva questions (5)
- Q: Which arch is typically dominant?A: The Right arch is larger in 75% of cases.
- Q: Does it cause cyanosis?A: No, it is a non-cyanotic vascular ring.
- Q: What is the Barium swallow finding?A: Bilateral compression of the esophagus.
- Q: Embryology?A: Persistence of both right and left fourth arches (right dorsal aorta fails to regress).
- Q: What must be checked before surgery?A: Which arch is dominant and whether each is patent — by CT or MRI.
58.Interrupted aortic arch
- Echo hallmark: Complete loss of luminal continuity between the ascending and descending aorta.
- Diagnosis: Interrupted Aortic Arch
- Clinical risk: Shock and acidemia upon ductus closure.
- Management: PGE1 infusion to keep ductus open, then surgical reconstruction.
Viva questions (5)
- Q: How does blood reach the lower body?A: Exclusively through the Patent Ductus Arteriosus.
- Q: What is the most common type?A: Type B (interruption between left carotid and left subclavian).
- Q: Genetic association?A: DiGeorge syndrome (22q11 deletion), especially Type B.
- Q: Associated cardiac defect?A: Almost always associated with a VSD.
- Q: Pulse check?A: Normal pulses in arms, absent femoral pulses.
59.Complete atrioventricular septal defect
- Echo hallmark: A single, common atrioventricular valve overriding an ostium primum ASD and an inlet VSD.
- Diagnosis: Complete AVSD (AV Canal)
- Clinical risk: Massive left-to-right shunting, early pulmonary hypertension.
- Management: Early surgical repair (patching septa, dividing valve).
Viva questions (5)
- Q: Strongest genetic association?A: Down syndrome (Trisomy 21).
- Q: Classic ECG finding?A: Superior QRS axis (Left Axis Deviation).
- Q: Echo feature of the common valve?A: Loss of normal offsetting; valves insert at the same level.
- Q: What is a "cleft"?A: A gap in the anterior leaflet of the left-sided valve component.
- Q: When is surgery performed?A: Usually at 3-6 months before fixed pulmonary hypertension develops.
60.Scimitar syndrome
- Echo hallmark: Anomalous venous drainage of the right lung into the Inferior Vena Cava.
- Diagnosis: Scimitar Syndrome
- Clinical risk: Right heart volume overload.
- Management: Surgical baffle of the scimitar vein to the LA if Qp:Qs >1.5 or symptoms.
Viva questions (5)
- Q: Why the name "Scimitar"?A: The anomalous vein on CXR resembles a curved Turkish sword.
- Q: What happens to the right lung?A: It is usually hypoplastic.
- Q: What is the arterial blood supply to the right lower lobe?A: Often anomalous systemic arteries from the descending aorta.
- Q: Is it a left-to-right shunt?A: Yes.
- Q: Diagnostic confirmation?A: Cardiac CT or MRI to define venous drainage.
Classes and cut-offs follow the ESC 2020–2024 and ACC/AHA guidelines current in October 2026; always apply your own institution's protocols.
